the Rate of Participation in Screening for PBC
Conditions
Brief summary
The study consists of recruiting a target population by sending a letter from the Regional Center for Cancer Screening in Ile de France. In the screening program, a battery of examinations will be carried out at inclusion, one year, 2 years, 3 years, 4 years and 5 years.
Detailed description
The patients will be recruited by correspondence by by sending a letter from the Regional Center for Cancer Screening in Ile de France. When the patient has agreed to participate, a screening program will be carried out The screening program includes performing a low-dose chest CT scan (STBD), spirometry, blood sampling (biobank + screening for cardiovascular risk factors) on inclusion, at 1 year and at 2 years. Subsequently, a telephone interview will be scheduled for 3 years to collect medical information, for a total follow-up period of 5 years. At each visit, a structured offer of smoking cessation will be proposed and a collection of the quality of life will be carried out. Each year, a telephone call from participants will be scheduled in order to maximize participation
Interventions
The screening program includes performing a low-dose chest CT scan (STBD), spirometry, blood sampling (biobank + screening for cardiovascular risk factors) on inclusion, at 1 year and at 2 years. Subsequently, a telephone interview will be scheduled for 3 years to collect medical information, for a total follow-up period of 5 years. At each visit, a structured offer of smoking cessation will be proposed and a collection of the quality of life will be carried out. Each year, a telephone call from participants will be scheduled in order to maximize participation
Sponsors
Study design
Eligibility
Inclusion criteria
* Women and men * Age: 55 to 74 years old * Smokers at more than 20 pack-years weaned for less than 15 years * Affiliated to a social security organization
Exclusion criteria
* Presence of signs of PBC * Subjects with a personal history of PBC of less than 5 years or under treatment * Presence of serious comorbidities involving the vital prognosis at 6 months * Subjects who have already benefited from a chest CT scan less than one year old. * Refusal to participate in the study * Absence of exposure to tobacco or insufficient exposure to tobacco or withdrawal \> 15 years * Patient on long-term oxygen therapy * Metal implants (thorax, spine) which can cause a deterioration in the quality of the image of the low dose scanner * Subject included in another study protocol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of population participation in PBC screening | Baseline |